Morgan Stanley Bionano Genomics, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.16 $1.07 Million - $2.17 Million	-1,872,095 Reduced 63.13%	1,093,339 $666,000
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $277,028 - $514,855	-261,348 Reduced 8.1%	2,965,434 $3.29 Million
Q4 2022 Feb 14, 2023	SELL	$1.4 - $25.4 $164,073 - $2.98 Million	-117,195 Reduced 3.5%	3,226,782 $4.71 Million
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $112,725 - $11.3 Million	313,127 Added 10.33%	3,343,977 $6.12 Million
Q2 2022 Oct 27, 2022	BUY	$12.3 - $27.3 $12.2 Million - $27.1 Million	991,810 Added 48.64%	3,030,850 $4.18 Million
Q2 2022 Aug 15, 2022	BUY	$12.3 - $27.3 $12.2 Million - $27.1 Million	991,810 Added 48.64%	3,030,850 $4.18 Million
Q1 2022 Oct 27, 2022	SELL	$16.6 - $32.3 $16.5 Million - $32 Million	-991,810 Reduced 32.72%	2,039,040 $5.26 Million
Q1 2022 May 13, 2022	BUY	$16.6 - $32.3 $7.96 Million - $15.5 Million	479,725 Added 30.77%	2,039,040 $5.26 Million
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $25.9 Million - $53.1 Million	867,290 Added 125.33%	1,559,315 $4.66 Million
Q3 2021 Nov 15, 2021	BUY	$51.4 - $68.2 $35.6 Million - $47.2 Million	692,025 New	692,025 $3.81 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.